Successful Cataract Surgery in a Patient with a Port Delivery System Implant for Diabetic Macular Edema.

ABSTRACT:

Introduction

The Port Delivery Platform (PDS) with ranibizumab is a novel, surgically implanted device designed for continuous intraocular anti-VEGF delivery, approved for neovascular age-related macular degeneration and other retinal vascular diseases, including diabetic macular edema (DME) and diabetic retinopathy. While it can reduce treatment burden, the PDS implant introduces unique surgical considerations, particularly during subsequent ocular procedures.

Case presentation

We report a case of successful cataract extraction and intraocular lens implantation in a 72-year-old female with a PDS implant for DME, enrolled in the Pagoda trial. Cataract surgery was performed via clear corneal incisions while carefully avoiding manipulation of the conjunctiva or implant. The pr

SUBMITTER: Chu J 

PROVIDER: S-EPMC12782618 | biostudies-literature | 2026 Jan-Dec

REPOSITORIES: biostudies-literature